+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Combined Polio Vaccine Market - Global Forecast 2025-2030- Product Image
Combined Polio Vaccine Market - Global Forecast 2025-2030- Product Image
Sale

Combined Polio Vaccine Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055757
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Combined Polio Vaccine Market is experiencing pivotal change, combining scientific innovation and global collaboration to drive more effective immunization solutions for the future. This report delivers actionable intelligence, tailored for senior leaders navigating evolving vaccine strategies and complex international environments.

Market Snapshot: Combined Polio Vaccine Market Growth Overview

The Combined Polio Vaccine Market grew from USD 2.63 billion in 2024 to USD 2.74 billion in 2025. It is expected to continue growing at a CAGR of 4.01%, reaching USD 3.34 billion by 2030. This steady trajectory underscores accelerating investments in advanced formulation science, with innovation focused on streamlining immunization protocols globally. Intensified industry partnerships are helping overcome previous limitations in logistics, regulation, and manufacturing, paving the way for extended market reach and more robust disease prevention initiatives.

Scope & Segmentation

  • Vaccine Types: Bivalent, Monovalent, Trivalent
  • Route of Administration: Injectable, Oral
  • Technology: Inactivated Poliovirus Vaccines, Live Attenuated Vaccines, Subunit Vaccines
  • Development Stage: Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Pre-Clinical Trials
  • End Users: Clinics, Community Health Centers, Hospitals, Public Health Laboratories
  • Geographical Coverage: Americas (including key US states and major countries in North and South America), Europe, Middle East & Africa (covering major economic and healthcare markets), Asia-Pacific (with focus on both developed and emerging healthcare systems)
  • Key Industry Players: Global pharmaceutical leaders and specialized biotech firms, including Astellas Pharma, GlaxoSmithKline, Pfizer, Serum Institute of India, Sanofi, Zydus Lifesciences Limited, and others

Key Takeaways for Senior Decision-Makers

  • Market momentum is driven by streamlined manufacturing and collaboration across public and private sectors to deliver efficient, multivalent vaccine solutions.
  • Regulatory harmonization and fast-tracked approval mechanisms are accelerating combined vaccine adoption in both established and new markets.
  • Thermostable vaccine designs are addressing logistical challenges, enabling reach into resource-constrained and remote regions with improved cold chain resilience.
  • Digital tracking technologies and supply chain innovation are optimizing real-time distribution, ensuring timely delivery and inventory transparency.
  • Strategic alliances, technology transfer, and multi-stakeholder initiatives are enabling tailored responses to local and global immunization challenges.

Tariff Impact and Industry Response for Combined Polio Vaccines

Recent United States tariffs affecting vaccine inputs and finished polio vaccine products have introduced added procurement and manufacturing complexity. Manufacturers are pursuing nearshoring strategies, while leading industry consortia are negotiating with regulatory authorities for public health exemptions. Stakeholders are responding with enhanced supply chain flexibility and realignment of pricing strategies to safeguard immunization program continuity and market access.

Methodology & Data Sources

This analysis utilizes a multi-phase research process, beginning with a comprehensive review of scientific literature, regulatory documents, and patent filings. Quantitative findings are supported by expert interviews and proprietary datasets, with scenario modeling deployed to anticipate market effects from regulatory and technological change. Data validation and peer review ensure methodological rigor and robust, actionable market intelligence.

Why This Report Matters

  • Enables strategic planning by clarifying evolving market segments, technology deployment, and investment priorities in the combined polio vaccine sector.
  • Supports decision-making in navigating shifting trade landscapes, international regulatory requirements, and emerging global collaboration frameworks.
  • Empowers organizations to identify partnership opportunities, streamline operations, and safeguard vaccine accessibility across multiple geographies.

Conclusion

As the Combined Polio Vaccine Market evolves, industry leaders who adapt supply chains, embrace collaborative innovation, and align with dynamic public health agendas will maximize both impact and growth. This report provides vital direction for informed, future-facing decisions in a critical sector of global healthcare.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Development of novel adjuvant technologies to boost mucosal and humoral immunity in resource-limited settings
5.2. Regulatory harmonization efforts to accelerate approval of newly combined fractional inactivated polio vaccine schedules
5.3. Clinical trial data demonstrating noninferior immunogenicity of hexavalent vaccines including polio components in low-income countries
5.4. Strategic partnerships between global health organizations and emerging biotech firms to localize combined polio vaccine manufacturing
5.5. Implementation of fractional dose intradermal IPV in combination vaccines to address global supply shortages
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Combined Polio Vaccine Market, by Vaccine Type
8.1. Introduction
8.2. Bivalent Vaccine
8.3. Monovalent Vaccine
8.4. Trivalent Vaccine
9. Combined Polio Vaccine Market, by Route Of Administration
9.1. Introduction
9.2. Injectable Administration
9.3. Oral Administration
10. Combined Polio Vaccine Market, by Technology
10.1. Introduction
10.2. Inactivated Poliovirus Vaccines
10.3. Live Attenuated Vaccines
10.4. Subunit Vaccines
11. Combined Polio Vaccine Market, by Development Stage
11.1. Introduction
11.2. Phase I Clinical Trials
11.3. Phase II Clinical Trials
11.4. Phase III Clinical Trials
11.5. Pre-Clinical Trials
12. Combined Polio Vaccine Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Community Health Centers
12.4. Hospitals
12.5. Public Health Laboratories
13. Americas Combined Polio Vaccine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Combined Polio Vaccine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Combined Polio Vaccine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Astellas Pharma Inc.
16.3.2. Bharat Immunologicals and Biologicals Corporation Limited
16.3.3. AstraZeneca PLC
16.3.4. Biological E. Limited
16.3.5. BioNTech SE
16.3.6. CSL Limited
16.3.7. Daiichi Sankyo Company, Limited.
16.3.8. GlaxoSmithKline PLC
16.3.9. Haffkine Bio-Pharmaceutical Corporation Ltd
16.3.10. Incepta Pharmaceuticals Ltd.
16.3.11. Merck & Co., Inc.
16.3.12. Mitsubishi Tanabe Pharma Corporation
16.3.13. Panacea Biotec Ltd.
16.3.14. Pfizer Inc.
16.3.15. Sanofi S.A.
16.3.16. Serum Institute of India Pvt. Ltd.
16.3.17. Sinovac Biotech Ltd.
16.3.18. Takeda Pharmaceutical Company Limited
16.3.19. Zydus Lifesciences Limited
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. COMBINED POLIO VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS COMBINED POLIO VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS COMBINED POLIO VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES COMBINED POLIO VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES COMBINED POLIO VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC COMBINED POLIO VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC COMBINED POLIO VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. COMBINED POLIO VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. COMBINED POLIO VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. COMBINED POLIO VACCINE MARKET: RESEARCHAI
FIGURE 26. COMBINED POLIO VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 27. COMBINED POLIO VACCINE MARKET: RESEARCHCONTACTS
FIGURE 28. COMBINED POLIO VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. COMBINED POLIO VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY BIVALENT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY BIVALENT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY MONOVALENT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY MONOVALENT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY TRIVALENT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY TRIVALENT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY INJECTABLE ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY INJECTABLE ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY INACTIVATED POLIOVIRUS VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY INACTIVATED POLIOVIRUS VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY PHASE I CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY PHASE I CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY PHASE II CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY PHASE II CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY PHASE III CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY PHASE III CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY PRE-CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY PRE-CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY PUBLIC HEALTH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL COMBINED POLIO VACCINE MARKET SIZE, BY PUBLIC HEALTH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS COMBINED POLIO VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS COMBINED POLIO VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES COMBINED POLIO VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES COMBINED POLIO VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 75. CANADA COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 76. CANADA COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 77. CANADA COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 78. CANADA COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 79. CANADA COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 80. CANADA COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 81. CANADA COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 82. CANADA COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 83. CANADA COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. CANADA COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. MEXICO COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 86. MEXICO COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 87. MEXICO COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 88. MEXICO COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 89. MEXICO COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 90. MEXICO COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 91. MEXICO COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 92. MEXICO COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 93. MEXICO COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. MEXICO COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 134. UNITED KINGDOM COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. UNITED KINGDOM COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. GERMANY COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 138. GERMANY COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 139. GERMANY COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. GERMANY COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. GERMANY COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. GERMANY COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. GERMANY COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 144. GERMANY COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 145. GERMANY COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. GERMANY COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. FRANCE COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 148. FRANCE COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 149. FRANCE COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. FRANCE COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. FRANCE COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. FRANCE COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. FRANCE COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 154. FRANCE COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 155. FRANCE COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. FRANCE COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. RUSSIA COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 164. RUSSIA COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 165. RUSSIA COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. RUSSIA COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. ITALY COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 168. ITALY COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 169. ITALY COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. ITALY COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. ITALY COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 172. ITALY COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 173. ITALY COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 174. ITALY COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 175. ITALY COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. ITALY COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. SPAIN COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 178. SPAIN COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 179. SPAIN COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. SPAIN COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. SPAIN COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. SPAIN COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. SPAIN COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 184. SPAIN COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 185. SPAIN COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. SPAIN COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 204. SAUDI ARABIA COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. SAUDI ARABIA COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. SOUTH AFRICA COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. DENMARK COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 218. DENMARK COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 219. DENMARK COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. DENMARK COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. DENMARK COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. DENMARK COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. DENMARK COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 224. DENMARK COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 225. DENMARK COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. DENMARK COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 233. NETHERLANDS COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 234. NETHERLANDS COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 235. NETHERLANDS COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. NETHERLANDS COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. QATAR COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 238. QATAR COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 239. QATAR COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 240. QATAR COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 241. QATAR COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 242. QATAR COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 243. QATAR COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 244. QATAR COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 245. QATAR COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. QATAR COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. FINLAND COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 248. FINLAND COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 249. FINLAND COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. FINLAND COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. FINLAND COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. FINLAND COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. FINLAND COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 254. FINLAND COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 255. FINLAND COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. FINLAND COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. SWEDEN COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 264. SWEDEN COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 265. SWEDEN COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SWEDEN COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. NIGERIA COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 274. NIGERIA COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 275. NIGERIA COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. NIGERIA COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. EGYPT COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 278. EGYPT COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 279. EGYPT COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. EGYPT COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. EGYPT COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. EGYPT COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. EGYPT COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 284. EGYPT COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 285. EGYPT COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. EGYPT COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. TURKEY COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 288. TURKEY COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 289. TURKEY COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. TURKEY COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. TURKEY COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 292. TURKEY COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 293. TURKEY COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 294. TURKEY COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 295. TURKEY COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. TURKEY COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. ISRAEL COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 304. ISRAEL COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 305. ISRAEL COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. ISRAEL COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. NORWAY COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 308. NORWAY COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 309. NORWAY COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 310. NORWAY COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 311. NORWAY COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 312. NORWAY COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 313. NORWAY COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 314. NORWAY COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 315. NORWAY COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. NORWAY COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. POLAND COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 318. POLAND COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 319. POLAND COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 320. POLAND COMBINED POLIO VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 321. POLAND COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 322. POLAND COMBINED POLIO VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 323. POLAND COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 324. POLAND COMBINED POLIO VACCINE MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 325. POLAND COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. POLAND COMBINED POLIO VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. SWITZERLAND COMBINED POLIO VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Combined Polio Vaccine Market report include:
  • Astellas Pharma Inc.
  • Bharat Immunologicals and Biologicals Corporation Limited
  • AstraZeneca PLC
  • Biological E. Limited
  • BioNTech SE
  • CSL Limited
  • Daiichi Sankyo Company, Limited.
  • GlaxoSmithKline PLC
  • Haffkine Bio-Pharmaceutical Corporation Ltd
  • Incepta Pharmaceuticals Ltd.
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.74 billion
Forecasted Market Value ( USD ) by 2030 $ 3.34 billion
Compound Annual Growth Rate4.0%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Live Attenuated Polio Vaccine Global Market Report 2025 - Product Image

Live Attenuated Polio Vaccine Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Inactivated Polio and Rabies Vaccines - Global Strategic Business Report - Product Image

Inactivated Polio and Rabies Vaccines - Global Strategic Business Report

  • Report
  • 470 Pages
  • Global
From
Polio Vaccines - Global Strategic Business Report - Product Image

Polio Vaccines - Global Strategic Business Report

  • Report
  • 277 Pages
  • Global
From
Inactivated Polio And Rabies Vaccines Global Market Report 2025 - Product Image

Inactivated Polio And Rabies Vaccines Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Infectious Vaccines Market - Global Forecast 2025-2030 - Product Image

Infectious Vaccines Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.